Posted by Michael Wonder on 05 Jun 2025
Roche’s Evrysdi tablet approved by European Commission as first and only for spinal muscular atrophy
4 June 2025 - Simplified storage and administration of new tablet formulation may provide greater freedom and independence for people with spinal muscular atrophy.
Roche announced today that the European Commission has approved a label extension for Evrysdi (risdiplam) to include a new, room temperature stable tablet for people living with spinal muscular atrophy.
